Aromatase inhibitors for the endocrine adjuvant treatment of breast cancer

被引：10

作者：

Ravdin, P ^{[1
]}

机构：

[1] Univ Texas, Hlth Sci Ctr, Dept Med Oncol, San Antonio, TX USA

来源：

LANCET | 2002年 / 359卷 / 9324期

关键词：

D O I：

10.1016/S0140-6736(02)09111-0

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2126 / 2127

页数：2

共 50 条

[1] Optimising adjuvant endocrine treatment of breast cancer with aromatase inhibitors
Fentiman, IS
[J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2006, 60 (06) : 689 - 693
[2] Defining the role of aromatase inhibitors in the adjuvant endocrine treatment of early breast cancer
Buzdar, Aman
Chlebowski, Rowan
Cuzick, Jack
Duffy, Sean
Forbes, John
Jonat, Walter
Ravdin, Peter
[J]. CURRENT MEDICAL RESEARCH AND OPINION, 2006, 22 (08) : 1575 - 1585
[3] Aromatase inhibitors as adjuvant treatment of breast cancer
Geisler, J
Lonning, PE
[J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2006, 57 (01) : 53 - 61
[4] Aromatase inhibitors: New endocrine treatment of breast cancer
Brueggemeier, RW
[J]. SEMINARS IN REPRODUCTIVE MEDICINE, 2004, 22 (01) : 31 - 43
[5] Evolution of aromatase inhibitors as an endocrine treatment for breast cancer
WR Miller
[J]. Breast Cancer Research, 8 (Suppl 2)
[6] Aromatase Inhibitors for Adjuvant Treatment of Postmenopausal Breast Cancer
不详
[J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2011, 53 (1366): : 47 - 48
[7] Use of aromatase inhibitors in the adjuvant treatment of breast cancer
Baum, M
[J]. ENDOCRINE-RELATED CANCER, 1999, 6 (02) : 231 - 234
[8] Adjuvant aromatase inhibitors for breast cancer
Howell, A
[J]. LANCET, 2005, 366 (9484): : 431 - 433
[9] Endocrine therapy trials of aromatase inhibitors for breast cancer in the adjuvant and prevention settings
Ingle, JN
[J]. CLINICAL CANCER RESEARCH, 2005, 11 (02) : 900S - 905S
[10] Musculoskeletal complications and aromatase inhibitors in adjuvant breast cancer treatment
Khalifa, P.
Lesur, A.
[J]. ONCOLOGIE, 2007, 9 : HS5 - HS10

← 1 2 3 4 5 →